# A Clinical Study Aims to Assess the Consistency of Clinical Efficacy in Gastric Cancer Treatment and Drug Susceptibility Outcomes Using a Novel Drug Susceptibility Testing Method

> **NCT06100003** · — · UNKNOWN · sponsor: **Funan Liu** · enrollment: 104 (estimated)

## Conditions studied

- Gastric Cancer
- Organoids

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06100003
- **Lead sponsor:** Funan Liu
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-10-18
- **Primary completion:** 2025-10-31
- **Final completion:** 2025-12-01
- **Target enrollment:** 104 (ESTIMATED)
- **Last updated:** 2024-02-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06100003

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06100003, "A Clinical Study Aims to Assess the Consistency of Clinical Efficacy in Gastric Cancer Treatment and Drug Susceptibility Outcomes Using a Novel Drug Susceptibility Testing Method". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06100003. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*